United Kingdom· GB-APID-10150511000001100
Aldactone 200mg/10ml solution for injection ampoules
A potassium canrenoate product containing potassium canrenoate, registered in United Kingdom by Imported (Germany). The same ATC class is registered in 9 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Potassium canrenoate is registered in 9 of 19 countries.
Countries holding a registration under ATC C03DA02 (potassium canrenoate), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Potassium canrenoate · ATC C03DA02
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Germany
- Italyprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
Price per daily dose
What a daily dose of potassium canrenoate costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Potassium canrenoate · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- IT Italy$0.82
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Potassium canrenoate
- Manufacturer
- Imported (Germany)
- Country
- United Kingdom (GB)
- ATC code
- C03DA02
- ATC class
- Potassium canrenoate
- Defined daily dose
- 0.4 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for potassium canrenoate.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Potassium canrenoate · interactions on record
5 records
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Potassium canrenoate in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALDACTONEESTEVE Pharmaceuticals GmbH, Berlín
- BelgiumSoldactone 200 mgContinental Pharma
- GermanyAldactoneEsteve Pharmaceuticals Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Aldactone
- Czechia · Aldactone
- Germany · Aldactone
- France · Canrenoate De Potassium Esteve
- Italy · Kanrenol, Luvion
- Poland · Aldactone
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9849a45c-ab82-411d-96ae-aedce9f9235f GET /v1/drugs/9849a45c-ab82-411d-96ae-aedce9f9235f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "10150511000001100",
"desc": "Aldactone 200mg/10ml solution for injection ampoules (Imported (Germany))",
"form": "Solution for injection",
"vpid": "10150311000001106",
"source": "dmd",
"vtm_id": "777272003",
"strength": "20 mg",
"substance": "Potassium canrenoate",
"ingredient": "Potassium canrenoate",
"supplier_code": "11820611000001101"
}See everything about potassium canrenoate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.